Award

Obscurins: new players in the development of hypertrophic cardiomyopathy

Description: Giant obscurins are multidomain proteins expressed in striated muscles that intimately surround sarcomeres at the level of M-bands and Z-disks where they play key roles in the regular assembly and integration of the contractile cytoskeleton with internal membranes and the sarcolemma. Sequencing analysis has revealed the presence of a missense mutation (R4344Q) in immunoglobulin domain 58 (Ig58) that has been causally linked to the development of hypertrophic cardiomyopathy (HCM) in humans. To decipher the molecular alterations taking place in the mutant myocardium, we generated a constitutive Knock-In (KI) mouse model carrying the R4344Q mutation in Ig58. Sedentary homozygous KI mice are viable and fertile. Morphological examination followed by echocardiographic and electrocardiographic measurements of KI hearts demonstrated the development of mild hypertrophy with aging, which was accompanied by significant tachycardia and spontaneous arrhythmia. Consistent with this, isolated cardiomyocytes prepared from 12 months old KI hearts exhibited significantly increased Ca2+ transients and faster contractility kinetics. These findings were further corroborated by our biochemical studies indicating that obscurins are in a complex with the SERCA2a pump, and that their association is considerably enhanced by the presence of the R4344Q mutation. Conversely, exertion of pathological stress via transaortic constriction in young adult KI animals exacerbated the harmful effects of the R4344Q mutation, leading to the development of profound cardiac hypertrophy and compromised function. Our research aims to unravel the molecular mechanisms that underlie cardiac impairment due to the R4344Q obscurin mutation under sedentary conditions (Aim 1) and following exertion pf physiological (e.g. rigorous exercise) and pathological (e.g. pressure overload) stress (Aim 2). The proposed studies will be the first to study the morphological and functional ramifications of a congenital mutation in the obscurin gene in the development of HCM under sedentary and stress conditions.
Amount: $154,000
Funding type: research
Funder scheme: Grant-in-Aid
Start date: 2016-07-01
End date: 2018-06-30
Field: Medicine
Funded outputs count: 6
Funder award ID: 16GRNT31290010
OpenAlex ID: G1231033405
2020 · Alyssa Grogan, Andrew Coleman, et al. · Basic Research in Cardiology · 27
2020 · Alyssa Grogan, Panagiotis Tsakiroglou, et al. · Biophysical Reviews · 16
2020 · Li-Yen R. Hu, Aikaterini Kontrogianni-Konstantopoulos · Frontiers in Physiology · 16
2018 · Alyssa Grogan, Aikaterini Kontrogianni-Konstantopoulos · Pflügers Archiv - European Journal of Physiology · 35
2017 · Maegen A. Ackermann, Brendan King, et al. · Journal of Molecular and Cellular Cardiology · 34
2017 · Li-Yen R. Hu, Maegen A. Ackermann, et al. · Science Advances · 45